Event Details

Event Details

Event Details

15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

11/29/22 - 12/02/22

Webcast Presentation

More information

Supporting Materials

CTAD 2022 poster LP-19: Pepinemab is a novel potential treatment for neurodegenerative disease 2.6 MB

Antibody Engineering and Therapeutics 2022 poster: ActivMAb - native complex membrane antigen expression for antibody discovery 3.2 MB

Title

15th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Date / Time

11/29/22 - 12/02/22